Matthew E. Griffin
Impact in
-
- Glycosylation and Glycoproteins Research
- Gut microbiota and health
- Biotechnology top 10%
Papers in
-
- Glycosylation and Glycoproteins Research 8
- Gut microbiota and health 3
-
- Proteoglycans and glycosaminoglycans research 7
- Co-authors
- Linda C. Hsieh‐Wilson (9 shared papers)Howard C. Hang (3 shared papers)Juliel Espinosa (2 shared papers)Ji‐Dung Luo (1 shared paper)Jyoti K. Jha (1 shared paper)Gary R. Fanger (1 shared paper)Thomas S. Carroll (1 shared paper)Abigail Pulsipher (3 shared papers)
- Journals
- Cell chemical biology (2 papers)Nature Chemical Biology (2 papers)ACS Chemical Biology (2 papers)Current Opinion in Chemical Biology (2 papers)Neoplasia (1 paper)
- Partner nations
- United StatesSouth KoreaArgentina
In The Last Decade
Matthew E. Griffin
19 papers receiving 797 citations
Matthew E. Griffin's Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 573
- Biotechnology 67
- Biological Psychiatry 19
- Immunology 149
- Cell Biology 105
Countries citing papers authored by Matthew E. Griffin
This map shows the geographic impact of Matthew E. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Griffin more than expected).
Fields of papers citing papers by Matthew E. Griffin
This network shows the impact of papers produced by Matthew E. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Griffin. The network helps show where Matthew E. Griffin may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Griffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy Hit paper breakdown → | 2021 | 241 |
| 2 | 2014 | 70 | |
| 3 | 2016 | 58 | |
| 4 | 2014 | 55 | |
| 5 | 2017 | 52 | |
| 6 | 2022 | 47 | |
| 7 | 2020 | 43 | |
| 8 | 2016 | 42 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 29 | |
| 11 | 2020 | 27 | |
| 12 | 2013 | 25 | |
| 13 | 2023 | 23 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 14 | |
| 16 | 2010 | 12 | |
| 17 | 2022 | 10 | |
| 18 | 2023 | 7 | |
| 19 | 2014 | 6 | |
| 20 | 2024 | 0 |
About Matthew E. Griffin
Matthew E. Griffin is a scholar working on Molecular Biology, Cell Biology, Organic Chemistry, Immunology and Oncology, having authored 20 papers that have together received 809 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Proteoglycans and glycosaminoglycans research (7 papers), Carbohydrate Chemistry and Synthesis (5 papers), Gut microbiota and health (3 papers), Bacterial Genetics and Biotechnology (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Tryptophan and brain disorders (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Molecular Biology (573 citations), Biotechnology (67 citations), Biological Psychiatry (19 citations), Immunology (149 citations) and Cell Biology (105 citations). Matthew E. Griffin has collaborated with scholars based in United States, South Korea and Argentina. Frequent co-authors include Linda C. Hsieh‐Wilson, Howard C. Hang, Juliel Espinosa, Ji‐Dung Luo, Jyoti K. Jha, Gary R. Fanger, Thomas S. Carroll, Abigail Pulsipher, Howard C. Hang and John W. Thompson. Their work appears in journals such as Cell chemical biology, Nature Chemical Biology, ACS Chemical Biology, Current Opinion in Chemical Biology and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.